170 related articles for article (PubMed ID: 29222092)
1. Targeted disruption of the
Hardege I; Long L; Al Maskari R; Figg N; O'Shaughnessy KM
Clin Sci (Lond); 2018 Jan; 132(1):145-156. PubMed ID: 29222092
[TBL] [Abstract][Full Text] [Related]
2. Regulation of aldosterone biosynthesis by the Kir3.4 (KCNJ5) potassium channel.
Velarde-Miranda C; Gomez-Sanchez EP; Gomez-Sanchez CE
Clin Exp Pharmacol Physiol; 2013 Dec; 40(12):895-901. PubMed ID: 23829355
[TBL] [Abstract][Full Text] [Related]
3. KCNJ5 mutations in aldosterone producing adenoma and relationship with adrenal cortex remodeling.
Boulkroun S; Golib Dzib JF; Samson-Couterie B; Rosa FL; Rickard AJ; Meatchi T; Amar L; Benecke A; Zennaro MC
Mol Cell Endocrinol; 2013 May; 371(1-2):221-7. PubMed ID: 23376008
[TBL] [Abstract][Full Text] [Related]
4. Human adrenal glomerulosa cells express K2P and GIRK potassium channels that are inhibited by ANG II and ACTH.
Enyeart JJ; Enyeart JA
Am J Physiol Cell Physiol; 2021 Jul; 321(1):C158-C175. PubMed ID: 34038243
[TBL] [Abstract][Full Text] [Related]
5. Primary Aldosteronism: Spatial Multiomics Mapping of Genotype-Dependent Heterogeneity and Tumor Expansion of Aldosterone-Producing Adenomas.
Gong S; Sun N; Meyer LS; Tetti M; Koupourtidou C; Krebs S; Masserdotti G; Blum H; Rainey WE; Reincke M; Walch A; Williams TA
Hypertension; 2023 Jul; 80(7):1555-1567. PubMed ID: 37125608
[TBL] [Abstract][Full Text] [Related]
6. Visinin-like 1 is upregulated in aldosterone-producing adenomas with KCNJ5 mutations and protects from calcium-induced apoptosis.
Williams TA; Monticone S; Crudo V; Warth R; Veglio F; Mulatero P
Hypertension; 2012 Apr; 59(4):833-9. PubMed ID: 22331379
[TBL] [Abstract][Full Text] [Related]
7. Transcriptome Pathway Analysis of Pathological and Physiological Aldosterone-Producing Human Tissues.
Zhou J; Lam B; Neogi SG; Yeo GS; Azizan EA; Brown MJ
Hypertension; 2016 Dec; 68(6):1424-1431. PubMed ID: 27777363
[TBL] [Abstract][Full Text] [Related]
8. Mutated KCNJ5 activates the acute and chronic regulatory steps in aldosterone production.
Hattangady NG; Karashima S; Yuan L; Ponce-Balbuena D; Jalife J; Gomez-Sanchez CE; Auchus RJ; Rainey WE; Else T
J Mol Endocrinol; 2016 Jul; 57(1):1-11. PubMed ID: 27099398
[TBL] [Abstract][Full Text] [Related]
9. Cellular and Genetic Causes of Idiopathic Hyperaldosteronism.
Omata K; Satoh F; Morimoto R; Ito S; Yamazaki Y; Nakamura Y; Anand SK; Guo Z; Stowasser M; Sasano H; Tomlins SA; Rainey WE
Hypertension; 2018 Oct; 72(4):874-880. PubMed ID: 30354720
[TBL] [Abstract][Full Text] [Related]
10. Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas.
Williams TA; Monticone S; Schack VR; Stindl J; Burrello J; Buffolo F; Annaratone L; Castellano I; Beuschlein F; Reincke M; Lucatello B; Ronconi V; Fallo F; Bernini G; Maccario M; Giacchetti G; Veglio F; Warth R; Vilsen B; Mulatero P
Hypertension; 2014 Jan; 63(1):188-95. PubMed ID: 24082052
[TBL] [Abstract][Full Text] [Related]
11. Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculata-like tumors.
Azizan EA; Lam BY; Newhouse SJ; Zhou J; Kuc RE; Clarke J; Happerfield L; Marker A; Hoffman GJ; Brown MJ
J Clin Endocrinol Metab; 2012 May; 97(5):E819-29. PubMed ID: 22442279
[TBL] [Abstract][Full Text] [Related]
12. NEFM (Neurofilament Medium) Polypeptide, a Marker for Zona Glomerulosa Cells in Human Adrenal, Inhibits D1R (Dopamine D1 Receptor)-Mediated Secretion of Aldosterone.
Maniero C; Garg S; Zhao W; Johnson TI; Zhou J; Gurnell M; Brown MJ
Hypertension; 2017 Aug; 70(2):357-364. PubMed ID: 28584012
[TBL] [Abstract][Full Text] [Related]
13. Renin knockout rat: control of adrenal aldosterone and corticosterone synthesis in vitro and adrenal gene expression.
Raff H; Gehrand A; Bruder ED; Hoffman MJ; Engeland WC; Moreno C
Am J Physiol Regul Integr Comp Physiol; 2015 Jan; 308(1):R73-7. PubMed ID: 25394830
[TBL] [Abstract][Full Text] [Related]
14. Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells.
Monticone S; Hattangady NG; Nishimoto K; Mantero F; Rubin B; Cicala MV; Pezzani R; Auchus RJ; Ghayee HK; Shibata H; Kurihara I; Williams TA; Giri JG; Bollag RJ; Edwards MA; Isales CM; Rainey WE
J Clin Endocrinol Metab; 2012 Aug; 97(8):E1567-72. PubMed ID: 22628608
[TBL] [Abstract][Full Text] [Related]
15. Zona Glomerulosa-Derived Klotho Modulates Aldosterone Synthase Expression in Young Female Mice.
Daryadel A; Tang C; Xie Y; Peitzsch M; Fisi V; Hantel C; Loffing-Cueni D; Breault DT; Penton D; Loffing J; Beuschlein F
Endocrinology; 2024 Mar; 165(5):. PubMed ID: 38573585
[TBL] [Abstract][Full Text] [Related]
16. A revised mechanism of action of hyperaldosteronism-linked mutations in cytosolic domains of GIRK4 (KCNJ5).
Shalomov B; Handklo-Jamal R; Reddy HP; Theodor N; Bera AK; Dascal N
J Physiol; 2022 Mar; 600(6):1419-1437. PubMed ID: 34957562
[TBL] [Abstract][Full Text] [Related]
17. Effect of Dietary Sodium Modulation on Pig Adrenal Steroidogenesis and Transcriptome Profiles.
Vohra T; Kemter E; Sun N; Dobenecker B; Hinrichs A; Burrello J; Gomez-Sanchez EP; Gomez-Sanchez CE; Wang J; Kinker IS; Teupser D; Fischer K; Schnieke A; Peitzsch M; Eisenhofer G; Walch A; Reincke M; Wolf E; Williams TA
Hypertension; 2020 Dec; 76(6):1769-1777. PubMed ID: 33070662
[TBL] [Abstract][Full Text] [Related]
18. Minireview: potassium channels and aldosterone dysregulation: is primary aldosteronism a potassium channelopathy?
Gomez-Sanchez CE; Oki K
Endocrinology; 2014 Jan; 155(1):47-55. PubMed ID: 24248457
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas.
Monticone S; Castellano I; Versace K; Lucatello B; Veglio F; Gomez-Sanchez CE; Williams TA; Mulatero P
Mol Cell Endocrinol; 2015 Aug; 411():146-54. PubMed ID: 25958045
[TBL] [Abstract][Full Text] [Related]
20. Functional characterization of two novel germline mutations of the KCNJ5 gene in hypertensive patients without primary aldosteronism but with ACTH-dependent aldosterone hypersecretion.
Sertedaki A; Markou A; Vlachakis D; Kossida S; Campanac E; Hoffman DA; Sierra ML; Xekouki P; Stratakis CA; Kaltsas G; Piaditis GP; Chrousos GP; Charmandari E
Clin Endocrinol (Oxf); 2016 Dec; 85(6):845-851. PubMed ID: 27293068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
